News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Nico Gagelmann: Closing the Gap – PTCy Boosts Survival After Mismatched Stem Cell Transplants
Nico Gagelmann
Jun 18, 2025, 15:13

Nico Gagelmann: Closing the Gap – PTCy Boosts Survival After Mismatched Stem Cell Transplants

Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X:

“Out now in Journal of Clinical Oncology.
Closing the Gap: PTCy Boosts Survival After Mismatched Stem Cell Transplants
Summary:
In a multicenter phase II trial, post-transplant cyclophosphamide (PTCy)-based GVHD prophylaxis enabled strong 1-year survival outcomes in patients receiving peripheral blood stem cell transplants from HLA-mismatched unrelated donors (MMUDs).
Among 145 patients – 59% from underrepresented groups – 1-year overall survival reached 83.8% (MAC) and 78.6% (RIC/NMA), with low rates of severe GVHD.
Outcomes were comparable regardless of the degree of mismatch. These findings suggest PTCy regimens can safely expand donor access across all ethnic backgrounds.”

Nico Gagelmann

More posts featuring Nico Gagelmann on OncoDaily.

Abeer Madbouly Alison Loren Antonio Martin Jimenez Jimenez ASCO Brent Logan Brian C. Shaffer Bronwen E. Shaw cancer Craig Malmberg Dipenkumar Modi EHA Erin Leckrone European Hematology Association Farhad Khimani Heather E. Stefanski Janelle Olson Jeffery J. Auletta Jianqun Kou Journal of Clinical Oncology Juan Wu Karen Ballen Karilyn Larkin Larisa Broglie Mahasweta Gooptu Martin Maiers Medhat Askar Mehdi Hamadani Monzr M. Al Malki Muna Qayed Nico Gagelmann OncoDaily Oncology post-transplant cyclophosphamide PTCy Rachel Cook Rachel Cusatis Sally Arai Sarah Smith Stem Cell Transplants Stephanie Bo-Subait Stephanie Fingerson Stephen R. Spellman Steven Michael Devine Sung Won Choi The EBMT
Special Coverage
Positive
Jul 9, 2025, 09:40
Garabet Yeretssian: Excited to See Launch of Center for Pediatric CRISPR Cures at UCSF and UC Berkeley
Career
Jul 9, 2025, 09:28
Caryn Lerman: Ricky Bluthenthal Has Been Appointed as Chair of the Department of Population and Public Health Sciences
Science
Jul 9, 2025, 09:22
Mario Balsa: Real-World Meets Real Impact!
Science
Jul 9, 2025, 09:12
Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski
Career
Jul 9, 2025, 08:22
Call for Applications: Young SIOP Representative for Nutrition Network Steering Group - AIEOP
Blog
Jul 9, 2025, 01:52
Zoë Mullan: Hope to See Some Familiar Faces at 2025 Asian Conference on Implementation Science
Insight
Jul 9, 2025, 01:44
Inhibiting CDS2 Selectively Kills CDS1-deficient Cancer Cells - The Netherlands Cancer Institute
Blog
Jul 8, 2025, 20:46
Experts Driving Innovation in Radiation Oncology Through the ESTRO Focus Group
Blog
Jul 8, 2025, 20:27
Abdu Adem Yesufe: Immensely Grateful for IAEA's Support Thus Far
Blog
Jul 8, 2025, 20:24
Svetlana Nikic: Honored to Attend HBA and Almirall Event on Women’s Development
Blog
Jul 8, 2025, 20:03
Alfredo Addeo: Colloquiums of the Department of Medicine in HUG Presented a Fascinating Conference
Blog
Jul 8, 2025, 19:47
A Webinar on "Overcoming Barriers to Pediatric Cancer Care in Nepal" on July 17 - The Max Foundation